Protocol Ledger

NCT07107256 · Phase III · ACTIVE NOT RECRUITING

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

Interventional Phase III clinical trial protocol NCT07107256 sponsored by Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-09-25 Enrollment: 246 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT07107256
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)246 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07107256
Protocol FieldVerified Registry Value
NCT IdentifierNCT07107256
Consolidated Lead SponsorShanghai Chia Tai Tianqing Pharmaceutical Technology Development Co
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment246 participants (ACTUAL)
Registered Start Date2025-09-25
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI